Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung im Erwachsenenalter

S. Groß; S. Matthies; A. Philipsen

doi:10.1055/s-0038-1627632

Nervenheilkunde, Table of Contents

Nervenheilkunde 2015; 34(10): 759-763
DOI: 10.1055/s-0038-1627632

Update Neurologie und Psychiatrie

Schattauer GmbH

Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung im Erwachsenenalter

Attention-deficit/hyperactivity disorder in adults

Authors

S. Groß

¹Fakultät für Medizin und Gesundheitswissenschaften, Medizinischer Campus Universität Oldenburg

²Universitäts-klinik für Psychiatrie und Psychotherapie, Karl-Jaspers-Klinik, Bad Zwischenahn
S. Matthies

³Abteilung für Psychiatrie und Psychotherapie, Universitätsklinikum Freiburg
A. Philipsen

¹Fakultät für Medizin und Gesundheitswissenschaften, Medizinischer Campus Universität Oldenburg

²Universitäts-klinik für Psychiatrie und Psychotherapie, Karl-Jaspers-Klinik, Bad Zwischenahn

Abstract

Zusammenfassung

Im Rahmen der Arbeit soll der aktuelle Stand der Forschung zur ADHS im Erwachsenenalter vorgestellt werden. Die Ursachen der ADHS sind noch nicht vollständig geklärt, es werden jedoch genetische und andere Einflussfaktoren wie prä-und perinatale Komplikationen angenommen. Daneben weisen ADHS-Patienten hirnorganisch strukturelle, neurochemische und funktionelle Auffälligkeiten auf. Die Diagnostik der ADHS im Erwachsenenalter basiert auf einem klinischen Interview, biografischer und Fremdanamnese sowie psychometrischen Erhebungen. Zudem sollten organische oder andere psychische Erkrankungen, die ADHS-ähnliche Symptome hervorrufen können, differenzialdiagnostisch ausgeschlossen werden. Erfolgt die Diagnosestellung nach DSM-5 müssen die Symptome vor dem 12. Lebensjahr aufgetreten sein. Bei der Behandlung der ADHS im Erwachsenenalter wird eine Kombination aus Pharmako-und Psychotherapie empfohlen. Neuere Behandlungsansätze wie die Supplementation von Vitaminen, Fettsäuren oder Mineralien, Sport oder Neurofeedback bedürfen einer weiteren Evaluation.

Summary

Aim of the paper is to present the current status of research on ADHD in adulthood. The etiology of adult ADHD is not entirely clarified, however genetic and other influencing factors like pre-and perinatal complications are assumed. Additionally, in patients with ADHD structural, neurochemical and functional brain abnormalities have been found. The diagnosis is based on a clinical interview (including significant others), biographical information and psychometric measurements. Furthermore organic or psychiatric diseases which cause ADHD-like symptoms should be ruled out. According to DSM-5 symptoms should be verifiable before the age of 12. A combination of pharmaco-and psychotherapy is recommended for treatment of adult ADHD. Newer treatment approaches like the supplementation of vitamins, fatty acids or minerals, athletics or neurofeedback require further investigation.

Schlüsselwörter

ADHS - Erwachsene - Diagnostik - Therapie

Keywords

ADHD - adults - diagnostic - therapy

Full Text

References

Literatur
1 Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K. et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007; 190: 402-9.
2 De Zwaan M, Gruss B, Müller A, Graap H, Martin A, Glaesmer H. et al. The estimated prevalence and correlates of adult ADHD in a German community sample. Eur Arch Psychiatry Clin Neurosci 2012; 262: 79-86.
3 Das D, Cherbuin N, Easteal S, Anstey KJ. Attention deficit/hyperactivity disorder symptoms and cognitive abilities in the late-life cohort of the PATH through Life Study. PLoS One 2014; 09: e86552.
4 Faraone SV, Mick E. Molecular genetics of attention-deficit hyperactivity disorder. Psychiatr Clin North Am 2010; 33: 159-80.
5 Hasler R, Salzmann A, Bolzan T, Zimmermann J, Baud P, Giannakopoulos P. et al. DAT1 and DRD4 genes involved in key dimensions of adult ADHD. Neurol Sci 2015; 36: 861-9.
6 Hammerschlag AR, Polderman TJ, de Leuuw C, Tiemeier H, White T, Smit AB. et al. Functional gene-set analysis does not support a major role for synaptic function in attention deficit/hyperactivity disorder. Genes 2014; 05: 604-14.
7 Franke B, Neale BM, Faraone SV. Genome-wide association studies in ADHD. Human Genetics 2009; 126: 13-50.
8 Langley K, Heron J, Smith GD, Thapar A. Maternal and parental smoking during pregnancy and risk of ADHD symptoms in offspring: testing for intrauterine effects. Am J Epidemiol 2012; 176: 261-8.
9 Morales E, Julvez J, Torrent M, Ballester F, Rodríguez-Bernal CL, Andiarena A. et al. Vitamin D in pregnancy and attention deficit hyperactivity disorder-like symptoms in childhood. Epidemiology 2015; 26: 458-65.
10 Durston S, van Belle J, de Zeeuw P. Differentiating frontostriatal and fronto-cerebellar circuits in attention-deficit/hyperactivity disorder. Biol Psychiatry 2011; 69: 1178-84.
11 Castellanos FX, Proall E. Large scale brain systems in ADHD: beyond the prefrontal-striatal model. Trends Cogn Sci 2012; 16: 17-26.
12 Cortese S, Kelly C, Chabernaud C, Proal E, Di Martino A, Milham MP. et al. Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. Am J Psychiatry 2012; 169: 1038-55.
13 Cubillo A, Halari R, Smith A, Taylor E, Rubia K. A review of fronto-striatal and fronto-cortical brain abnormalities in children and adults with Attention Deficit Hyperactivity Disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention. Cortex 2012; 48: 194-215.
14 Retz-Junginger P, Retz W, Blocher D, Stieglitz RD, Tritt GE, Wender PH. et al. Wender Utah Rating Scale (WURS-k): Die deutsche Kurzform zur retrospektiven Erfassung des hyperkinetischen Syndroms bei Erwachsenen. Nervenarzt 2003; 73: 830-8.
15 Rösler M, Retz-Junginger P, Retz W, Stieglitz RD. HASE. Homburger ADHS-Skalen für Erwachsene. Göttingen: Hogrefe; 2008
16 Schmidt S, Petermann F. ADHS-E. ADHS-Screening für Erwachsene. Göttingen: Hogrefe; 2009
17 Christiansen H, Hirsch O, Abdel-Hamid M, Kiss B. Conners Skalen zur Aufmerksamkeit und Verhalten für Erwachsene. Bern: Huber; 2014
18 American Psychiatric Association. Diagnostisches und Statistisches Manual Psychischer Störungen – DMS-5. Hogrefe: Göttingen; 2014
19 Mowinckel AM, Lund MPedersen, Eilertsen E, Biele GA. Meta-analysis of decision-making and attention in adults with ADHD. J Atten Disord 2015; 19: 355-67.
20 Grane VA, Endestad T, Pinto AF, Solbakk AK. Attentional control and subjective executive function in treatment-naïve adults with Attention Deficit Hyperactivity Disorder. PloS One 2014; 09: e115227.
21 Alderson RM, Kasper LJ, Hudec KL, Patros CH. Attention-deficit/hyperactivity disorder (ADHD) and working memory in adults: a meta-analytic review. Neuropsychology 2013; 27: 287-302.
22 Marx I, Höpcke C, Berger C, Wandschneider R, Herpertz SC. The impact of financial reward contingencies on cognitive function profiles in adult ADHD. PLoS One 2013; 08: e67002.
23 Lenartowicz A, Loo SK. Use of EEG to diagnose ADHD. Curr Psychiatry Rep 2014; 16: 498.
24 Mueller A, Candrian G, Grane VA, Kroptov JD, Ponomarev VA, Baschera GM. Discriminating between ADHD adults and controls using independent ERP components and a support vector machine: a validation study. Nonlinear Biomed Phys 2011; 05: 5.
25 Ebert D, Krause J, Sackenheim C. et al. ADHS im Erwachsenenalter – Leitlinien auf Basis eines Expertenkonsensus mit Unterstützung der DGPPN. Nervenarzt 2003; 74: 939-945.
26 Adler LA, Spencer TJ, Milton DR, Moore RJ, Michelson D. Long-term, open-label safety and efficacy of Atomoxetin in adults with ADHD. J Atten Disord 2008; 12: 248-253.
27 Adler LA. et al. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month double-blind trial. J Clin Psychopharmacol 2009; 29: 44-50.
28 Adler LA. et al. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety 2008; 26: 212-221.
29 Wilens TE. et al. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend 2008; 96: 145-54.
30 Fridman M, Hodgkins PS, Kahle JS, Erder MH. Predicted effect size of lisdexamfetamine treatment of attention deficit/hyperacitivy disorder (ADHD) in European adults: Estimates based on indirect analysis using systematic review and meta-regression analysis. Eur Psychiatry. 2015 10.1016/j.eurpsy.2015.01.001.
31 Potter AS, Dunbar G, Mazzulla E, Hosford D, Newhouse PA. AZD3480, a novel nicotinic rezeptor agonist, for the treatment of attention-deficit/ hyperactivity disorder in adults. Biol Psychiatry 2014; 75: 207-14.
32 Rostain AL, Ramsay JR. A combined treatment approach for adults with ADHD – results of an open study of 43 patients. J Atten Disord 2006; 10: 150-9.
33 Emilson B, Gujonsson G, Sigurdsson JF, Baldursson G, Einarsson E, Olafsdottir H. et al. Cognitive behavior therapy in medication-treated adults with ADHD and persistent Symptoms: A randomized trial. BMC Psychiatry 2011; 11: 116.
34 Philipsen A, Richter H, Peters J, Alm B, Sobanski E, Colla M. et al. Structured group psychotherapy in adults with attention deficit hyperactivity disorder: results of an open multicentre study. J Nerv Ment Dis 2007; 195: 1013-19.
35 Petterson R, Söderström S, Edlund-Söderström K, Nilsson KW. Internet-based cognitive behavioral therapy for adults with ADHD in outpatient psychiatric care: a randomized trial. J Atten Disord. 2014 Epub ahead of print..
36 Schoenberg PL, Hepark S, Kann CC, Barendregt HP, Buitelaar JK, Speckens AE. Effects of mindfulness-based cognitive therapy on neurophysiological correlates of performance monitoring in adult attention-deficit/hyperactivity disorder. Clin Neurophysiol 2014; 125: 1407-16.
37 Bink M, van Nieuwenhuizen C, Popma A, Bongers IL, van Boxtel GJ. Behavioral effects of neurofeedback in adolescents with ADHD: a randomized controlled trial. Eur Child Adolesc Psychiatry. 2014 Epub ahead of print..
38 Ko IG, Kim SE, Kim TW, Ji ES, Shin MS, Kim CJ. et al. Swimming exercise alleviates the symptoms of attention-deficit hyperactivity disorder in spontaneous hypertensive rats. Mol Med Rep 2013; 08: 393-400.
39 Abramovitch A, Goldzweig G, Schweiger A. Correlates of physical activity with intrusive thoughts, worry and impulsivity in adults with attention deficit/hyperactivity disorder: a cross sectional pilot study. Isr J Psychiatry Relat Sci 2013; 50: 47-54.
40 Choi JW, Han DH, Kang KD, Jung HY, Renshaw PF. Aerobic exercise and attention deficit hyperactivity disorder: brain research. Med Sci Sports Exerc 2015; 47: 33-9.
41 Rucklidge JJ, Frampton CM, Gorman B, Boggis A. Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomized placebo-controlled trial. Br J Psychiatry 2014; 204: 306-15.
42 Bloch MH, Qawasmi A. Omega-3-fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: a systematic review and metaanalysis. J Am Acad Child Adolesc Psychiatry 2011; 50: 991-1000.